| |
|
|
|
AzurRx BioPharma Inc.  
|
|
2.6 0.13 (0.05%) |
04-22 16:00 |
|
Open: |
2.5 |
Pre close: |
2.47 |
Target:
|
3.15
|
|
High: |
2.62 |
Low: |
2.5 |
Resistance:
|
2.70
3.15
|
|
Volume: |
259,701 |
Market Cap: |
52M |
Support:
|
2.27
 2.01
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.50
|
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
2.47 |
Signal(12,26,9): |
0.10  |
|
MA(100): |
2.04 |
Stochastic Oscillator |
%K(14,3):
|
61.22 |
|
MA(250): |
2.39 |
%D(3): |
57.37 |
|
Average Volume(K) |
3-Month: |
9438
|
52-Week |
High:
|
3.75 |
|
10-Days: |
10236 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
61.18 |
Change(%): |
-14.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-446.4 |
Shares Out. (M) |
19.83 |
|
EPS Est. Current Year |
-0.850 |
Return on Assets (ttm) |
-212.9 |
Shares Float (M) |
18.90 |
|
EPS Est. Next Year |
-0.670 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
15.90 |
|
Forward EPS |
-0.640 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
10.980 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.24 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.87 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-6.37 |
P/CF |
-4.74 |
|
|
|
|
|
|
